By New York TimesThree doctors at the National Institutes of Health have sharply criticized Eli Lilly and Co. for its efforts to promote the use of Xigris, an expensive treatment for patients with sepsis. In an article published in the New England Journal of Medicine, the doctors wrote that Lilly had manipulated treatment guidelines for sepsis patients to promote Xigris at the expense of older, cheaper and equally effective treatments. In response to the article, Lilly said it had behaved properly and disclosed its role in financing a task force of doctors and scientists that devised the treatment guidelines.
Read the full Times story. (Registration required)Access the NEJM article. (Subscribers only)